Today: 12 May 2026
Celsius Stock Rallies After Earnings Beat as Alani Nu and Rockstar Lift Sales
7 May 2026
2 mins read

Celsius Stock Rallies After Earnings Beat as Alani Nu and Rockstar Lift Sales

BOCA RATON, Fla., May 7, 2026, 08:04 ET

  • Celsius turned in record Q1 revenue at $782.6 million, a 138% jump, with adjusted diluted EPS at 41 cents.
  • Premarket, shares jumped up to 10% after the company posted sales and adjusted earnings ahead of analyst forecasts.
  • Alani Nu and Rockstar delivered bigger numbers this quarter, though gross margin slipped to 48.3%. Integration costs and commodity prices aren’t going away, keeping pressure on results.

Celsius Holdings soared Thursday, popping up to 10% before the bell after the company posted first-quarter numbers that topped Street forecasts. The energy-drink player delivered $782.6 million in revenue—well ahead of the $764.4 million analysts had penciled in—and reported adjusted earnings per share above estimates. Sales growth was fueled in part by Alani Nu and Rockstar Energy as Celsius made further inroads in U.S. energy drinks.

Investors zeroed in on these results, looking for evidence that Celsius was converting last year’s deal spree into real, streamlined growth instead of piling on more layers. In April 2025, the company snapped up Alani Nu; then, in August, it took over Rockstar Energy’s U.S. and Canadian operations. That put this quarter in the spotlight as the first real gauge of whether the expanded lineup could actually deliver under PepsiCo’s distribution umbrella.

The timing worked in both directions. JPMorgan’s Andrea Teixeira trimmed the firm’s price target on Celsius down to $67 from $77 ahead of the earnings release, but stuck with an Overweight call. She pointed out that sentiment was shaky, so expectations going into the results were already muted.

Celsius reported revenue of $782.6 million, a jump from $329.3 million in the same period last year. Net income reached $110.1 million. Diluted earnings per share climbed to 33 cents, up from 15 cents; on an adjusted basis, which strips out certain items, diluted EPS landed at 41 cents.

First-quarter sales for Alani Nu reached roughly $368.1 million, driven in part by demand and a boost from its rollout into the PepsiCo distribution network. Rockstar Energy chipped in with sales of about $66.6 million. The flagship CELSIUS brand posted growth of around 6%.

John Fieldly, chairman and CEO, called it a “defining period” for the company, adding that brand integration was “firmly on track.” Celsius grabbed roughly 20.9% dollar share in the U.S. energy-drink space during the quarter, spanning CELSIUS, Alani Nu and Rockstar. SEC

Retail numbers painted a mixed, but generally solid, picture. Celsius reported a 29.8% jump in portfolio retail sales across tracked U.S. channels for the 13 weeks ending March 29. Alani Nu sales doubled. CELSIUS brand sales picked up 6%, while Rockstar Energy slid 13%. RTD, or ready-to-drink, refers to shelf-stable canned and bottled beverages.

International sales jumped 55% to $35.3 million, driven by strong results out of the Nordics as well as the UK, Ireland, France, Australia, New Zealand, and Benelux. Still, North America continues to dominate, generating $747.3 million in first-quarter revenue.

Margin’s where things get tricky. Gross margin dropped by four points to 48.3%. Celsius linked that decline to its recent pickups—Alani Nu and Rockstar—both run thinner margins. They also flagged higher commodity costs. Still, management noted raw material costs had eased up from Q4, crediting better procurement.

It’s still a packed field. Last year, Reuters said PepsiCo’s bigger stake in Celsius—and their portfolio agreement—were supposed to boost Celsius’s chances in a U.S. energy-drink market where Red Bull and Monster Beverage have held sway for years. Jefferies analysts back then noted Celsius had started to wield more power in retail shelf space and promotions, thanks to PepsiCo naming it the U.S. energy “captain.” Reuters

Celsius unveiled its $1.8 billion cash-and-stock buyout of Alani Nu in 2025, targeting a broader footprint in both energy and wellness beverages. Back then, Needham’s Gerald Pascarelli pointed to Alani’s “meaningful distribution whitespace”—a claim getting put to the test now as the brand flows into the PepsiCo network. Reuters

Celsius repurchased roughly $24.1 million in shares over the quarter. Executives planned to review the numbers with investors during an 8 a.m. ET webcast.

Stock Market Today

  • ASX set to dip after budget scraps 50% capital gains tax discount
    May 12, 2026, 5:32 PM EDT. The Australian federal budget removed the 50% capital gains tax (CGT) discount on investments, aiming to correct undercompensation for inflation's impact on shares. This move targets intergenerational housing inequality by shifting investment incentives from property to stocks and new properties. While some investors like Liam Walsh, with $3 million in growth shares, anticipate personal losses, they acknowledge the policy's broader merit. Economists warn that the prior CGT settings favored property wealth accumulation, limiting opportunities for new investors. The reforms are expected to encourage investment decisions driven by economic factors rather than tax avoidance, potentially reshaping Australia's wealth-building landscape.

Latest article

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

12 May 2026
Tesla shares fell 2.7% to $433.45 after U.S. inflation data pushed Treasury yields higher and Reuters reported long waits and spotty robotaxi service in Texas. The stock swung from a high of $447.56 to a low of $422.39. Tesla’s valuation remains near $1.53 trillion, with a price-to-earnings ratio close to 398. Management cited cautious robotaxi rollout and increased 2026 capital spending above $25 billion.
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Micron Stock Gets $740 AI Call as Mizuho Lifts Western Digital, SanDisk Bets
Previous Story

Micron Stock Gets $740 AI Call as Mizuho Lifts Western Digital, SanDisk Bets

McDonald’s Q1 Earnings Beat Has One Catch: Value Meals Still Face a U.S. Test
Next Story

McDonald’s Q1 Earnings Beat Has One Catch: Value Meals Still Face a U.S. Test

Go toTop